Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer

Summary

This phase II trial studies how well pembrolizumab works in treating patients with non-squamous non-small cell lung cancer which has spread to other places in the body. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.

Timeline

Start

2016-10

Primary completion

2024-04-09

Completion

2024-04-09

Drugs

Indications